Literature DB >> 8642290

An insulin peptide that binds an alternative site in class II major histocompatibility complex.

S M Tompkins1, J C Moore, P E Jensen.   

Abstract

We report that a peptide from the B chain of insulin, B(10-30), binds with high affinity to multiple class II proteins, including IAb,d,k, IEd,k, and DR1. The ability of B(10-30) to inhibit the binding of other peptide antigens to class II does not correlate with its affinity for class II. B(10-30) only weakly inhibits the binding of antigenic peptides. Conversely, peptides with high affinity for the peptide-binding groove of various class II proteins do not inhibit B(10-30) binding. The rate of association of B(10-30) with class II is unusually rapid, approaching saturation in 1-2 h compared with 1-2 d for classical peptide antigens in the same conditions. The dissociation rate is also relatively rapid. The B(10-30) peptide inhibits the binding of the super-antigen staphylococcal enterotoxin B (SEB) to IAk. It also inhibits SEB-mediated T cell activation. These observations support the conclusion that B(10-30) binds to a site outside the peptide-binding groove. Our findings indicate that short-lived peptide-class II complexes can be formed through interactions involving the SEB-binding site and raise the possibility that alternative complexes may serve as T cell receptor ligands.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642290      PMCID: PMC2192356          DOI: 10.1084/jem.183.3.857

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  57 in total

1.  Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.

Authors:  P R Scholl; A Diez; R S Geha
Journal:  J Immunol       Date:  1989-10-15       Impact factor: 5.422

2.  T cells from nonresponder mice. MHC restricted and unrestricted recognition of insulin.

Authors:  P E Jensen; A O Kraft
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

3.  Binding of staphylococcal enterotoxin A to purified murine MHC class II molecules in supported lipid bilayers.

Authors:  J M Lee; T H Watts
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

4.  The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.

Authors:  D R Karp; C L Teletski; P Scholl; R Geha; E O Long
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

5.  High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.

Authors:  P A Roche; P Cresswell
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

6.  Characterization of the specificity of peptide binding to four DR haplotypes.

Authors:  D O'Sullivan; J Sidney; E Appella; L Walker; L Phillips; S M Colón; C Miles; R W Chesnut; A Sette
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

7.  Superantigens interact with MHC class II molecules outside of the antigen groove.

Authors:  P Dellabona; J Peccoud; J Kappler; P Marrack; C Benoist; D Mathis
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

8.  Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.

Authors:  J Alexander; J Sidney; S Southwood; J Ruppert; C Oseroff; A Maewal; K Snoke; H M Serra; R T Kubo; A Sette
Journal:  Immunity       Date:  1994-12       Impact factor: 31.745

9.  Stimulation of B10.BR T cells with superantigenic staphylococcal toxins.

Authors:  J E Callahan; A Herman; J W Kappler; P Marrack
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

Review 10.  The staphylococcal enterotoxins and their relatives.

Authors:  P Marrack; J Kappler
Journal:  Science       Date:  1990-05-11       Impact factor: 47.728

View more
  6 in total

Review 1.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Catalysis of peptide dissociation from class II MHC-peptide complexes.

Authors:  L Schmitt; J R Kratz; M M Davis; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex.

Authors:  J D Rabinowitz; K Tate; C Lee; C Beeson; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  T cell receptor restriction of diabetogenic autoimmune NOD T cells.

Authors:  E Simone; D Daniel; N Schloot; P Gottlieb; S Babu; E Kawasaki; D Wegmann; G S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 5.  Multiple genes/multiple autoantigens role in type 1 diabetes.

Authors:  N Abiru; G S Eisenbarth
Journal:  Clin Rev Allergy Immunol       Date:  2000-02       Impact factor: 10.817

6.  Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to alpha/beta T cells by the class Ib gene product, Qa-1(b).

Authors:  S M Tompkins; J R Kraft; C T Dao; M J Soloski; P E Jensen
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.